» Articles » PMID: 34697668

Obesity, Senescence, and Senolytics

Overview
Specialty Pharmacology
Date 2021 Oct 26
PMID 34697668
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Obesity is a major risk factor for the development of comorbidities such as type 2 diabetes, neurodegenerative disorders, osteoarthritis, cancer, cardiovascular and renal diseases. The onset of obesity is linked to an increase of senescent cells within adipose tissue and other organs. Cellular senescence is a stress response that has been shown to be causally linked to aging and development of various age-related diseases such as obesity. The senescence-associated-secretory phenotype of senescent cells creates a chronic inflammatory milieu that leads to local and systemic dysfunction. The elimination of senescent cells using pharmacological approaches (i.e., senolytics) has been shown to delay, prevent, or alleviate obesity-related organ dysfunction.

Citing Articles

Obesity-associated Inflammation and Alloimmunity.

Zhou H, Gizlenci M, Xiao Y, Martin F, Nakamori K, Zicari E Transplantation. 2024; .

PMID: 39192462 PMC: 11868468. DOI: 10.1097/TP.0000000000005183.


High-fat and high-carbohydrate diets increase bone fragility through TGF-β-dependent control of osteocyte function.

Dole N, Betancourt-Torres A, Kaya S, Obata Y, Schurman C, Yoon J JCI Insight. 2024; 9(16).

PMID: 39171528 PMC: 11343608. DOI: 10.1172/jci.insight.175103.


Targeting Cell Senescence and Senolytics: Novel Interventions for Age-Related Endocrine Dysfunction.

Suda M, Paul K, Tripathi U, Minamino T, Tchkonia T, Kirkland J Endocr Rev. 2024; 45(5):655-675.

PMID: 38500373 PMC: 11405506. DOI: 10.1210/endrev/bnae010.


Effect of Cellular Senescence in Disease Progression and Transplantation: Immune Cells and Solid Organs.

Kirchner V, Badshah J, Hong S, Martinez O, Pruett T, Niedernhofer L Transplantation. 2023; 108(7):1509-1523.

PMID: 37953486 PMC: 11089077. DOI: 10.1097/TP.0000000000004838.


"Bone-SASP" in Skeletal Aging.

Fang C, Liu B, Wan M Calcif Tissue Int. 2023; 113(1):68-82.

PMID: 37256358 PMC: 10230496. DOI: 10.1007/s00223-023-01100-4.


References
1.
Carlos Acosta J, Banito A, Wuestefeld T, Georgilis A, Janich P, Morton J . A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat Cell Biol. 2013; 15(8):978-90. PMC: 3732483. DOI: 10.1038/ncb2784. View

2.
Ahima R . Connecting obesity, aging and diabetes. Nat Med. 2009; 15(9):996-7. DOI: 10.1038/nm0909-996. View

3.
Alimirah F, Pulido T, Valdovinos A, Alptekin S, Chang E, Jones E . Cellular Senescence Promotes Skin Carcinogenesis through p38MAPK and p44/42MAPK Signaling. Cancer Res. 2020; 80(17):3606-3619. PMC: 7484313. DOI: 10.1158/0008-5472.CAN-20-0108. View

4.
Baker D, Wijshake T, Tchkonia T, LeBrasseur N, Childs B, van de Sluis B . Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature. 2011; 479(7372):232-6. PMC: 3468323. DOI: 10.1038/nature10600. View

5.
Barzilai N, Gupta G . Interaction between aging and syndrome X: new insights on the pathophysiology of fat distribution. Ann N Y Acad Sci. 2000; 892:58-72. DOI: 10.1111/j.1749-6632.1999.tb07785.x. View